Review



two-dimensional (2d) in-vitro cancer model  (BioMimetic Therapeutics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    BioMimetic Therapeutics two-dimensional (2d) in-vitro cancer model
    In experimental module, non-resistant and temozolomide (TMZ)-resistant human glioblastoma (hGB) cells were tumoroid-cultured using self-filling microwell arrays (SFMAs). After four days, allowing to form a compact solid tumor structure, tumoroids were co-cultured with NPC-differentiated neurons in a hydrogel matrix within a microfluidic chip. The growth and invasion of tumoroids were monitored over 7 days and were quantified via ImageJ. In <t>the</t> <t>HDC</t> framework, non-resistant and TMZ-resistant cells were two-dimensional <t>(2D)</t> cultured, their metabolic rates were extracted and input to the model, and predictions were validated by comparing with the experimental data. Created with BioRender.com.
    Two Dimensional (2d) In Vitro Cancer Model, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/two-dimensional+(2d)+in-vitro+cancer+model/3d+in+vitro+models/pmc11589919-38-18-16
    Average 90 stars, based on 1 article reviews
    two-dimensional (2d) in-vitro cancer model - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Insights from a multiscale framework on metabolic rate variation driving glioblastoma multiforme growth and invasion"

    Article Title: Insights from a multiscale framework on metabolic rate variation driving glioblastoma multiforme growth and invasion

    Journal: Communications Engineering

    doi: 10.1038/s44172-024-00319-9

    In experimental module, non-resistant and temozolomide (TMZ)-resistant human glioblastoma (hGB) cells were tumoroid-cultured using self-filling microwell arrays (SFMAs). After four days, allowing to form a compact solid tumor structure, tumoroids were co-cultured with NPC-differentiated neurons in a hydrogel matrix within a microfluidic chip. The growth and invasion of tumoroids were monitored over 7 days and were quantified via ImageJ. In the HDC framework, non-resistant and TMZ-resistant cells were two-dimensional (2D) cultured, their metabolic rates were extracted and input to the model, and predictions were validated by comparing with the experimental data. Created with BioRender.com.
    Figure Legend Snippet: In experimental module, non-resistant and temozolomide (TMZ)-resistant human glioblastoma (hGB) cells were tumoroid-cultured using self-filling microwell arrays (SFMAs). After four days, allowing to form a compact solid tumor structure, tumoroids were co-cultured with NPC-differentiated neurons in a hydrogel matrix within a microfluidic chip. The growth and invasion of tumoroids were monitored over 7 days and were quantified via ImageJ. In the HDC framework, non-resistant and TMZ-resistant cells were two-dimensional (2D) cultured, their metabolic rates were extracted and input to the model, and predictions were validated by comparing with the experimental data. Created with BioRender.com.

    Techniques Used: Cell Culture



    Similar Products

    two-dimensional (2d) in-vitro cancer model  (BioMimetic Therapeutics)
    90
    BioMimetic Therapeutics two-dimensional (2d) in-vitro cancer model
    In experimental module, non-resistant and temozolomide (TMZ)-resistant human glioblastoma (hGB) cells were tumoroid-cultured using self-filling microwell arrays (SFMAs). After four days, allowing to form a compact solid tumor structure, tumoroids were co-cultured with NPC-differentiated neurons in a hydrogel matrix within a microfluidic chip. The growth and invasion of tumoroids were monitored over 7 days and were quantified via ImageJ. In <t>the</t> <t>HDC</t> framework, non-resistant and TMZ-resistant cells were two-dimensional <t>(2D)</t> cultured, their metabolic rates were extracted and input to the model, and predictions were validated by comparing with the experimental data. Created with BioRender.com.
    Two Dimensional (2d) In Vitro Cancer Model, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/two-dimensional+(2d)+in-vitro+cancer+model/3d+in+vitro+models/pmc11589919-38-18-16
    Average 90 stars, based on 1 article reviews
    two-dimensional (2d) in-vitro cancer model - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    In experimental module, non-resistant and temozolomide (TMZ)-resistant human glioblastoma (hGB) cells were tumoroid-cultured using self-filling microwell arrays (SFMAs). After four days, allowing to form a compact solid tumor structure, tumoroids were co-cultured with NPC-differentiated neurons in a hydrogel matrix within a microfluidic chip. The growth and invasion of tumoroids were monitored over 7 days and were quantified via ImageJ. In the HDC framework, non-resistant and TMZ-resistant cells were two-dimensional (2D) cultured, their metabolic rates were extracted and input to the model, and predictions were validated by comparing with the experimental data. Created with BioRender.com.

    Journal: Communications Engineering

    Article Title: Insights from a multiscale framework on metabolic rate variation driving glioblastoma multiforme growth and invasion

    doi: 10.1038/s44172-024-00319-9

    Figure Lengend Snippet: In experimental module, non-resistant and temozolomide (TMZ)-resistant human glioblastoma (hGB) cells were tumoroid-cultured using self-filling microwell arrays (SFMAs). After four days, allowing to form a compact solid tumor structure, tumoroids were co-cultured with NPC-differentiated neurons in a hydrogel matrix within a microfluidic chip. The growth and invasion of tumoroids were monitored over 7 days and were quantified via ImageJ. In the HDC framework, non-resistant and TMZ-resistant cells were two-dimensional (2D) cultured, their metabolic rates were extracted and input to the model, and predictions were validated by comparing with the experimental data. Created with BioRender.com.

    Article Snippet: Here, we report on a hybrid discrete-continuum (HDC) mathematical framework that uses metabolic data from a biomimetic two-dimensional (2D) in-vitro cancer model to predict three-dimensional (3D) behaviour of in-vitro human glioblastoma (hGB).

    Techniques: Cell Culture